Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12609000884202
Ethics application status
Approved
Date submitted
9/10/2009
Date registered
12/10/2009
Date last updated
3/03/2010
Type of registration
Prospectively registered

Titles & IDs
Public title
A randomised, assessor blind, parallel group, comparative trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion, NeutraLice Advance and Moov Head Lice Solution) After a Single Application
Scientific title
A randomised, assessor blind, parallel group, comparative trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion, NeutraLice Advance and Moov Head Lice Solution) After a Single Application to primary school-aged children
Secondary ID [1] 1110 0
KEY/NL/003
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
head lice infestation 251968 0
Condition category
Condition code
Skin 252158 252158 0 0
Dermatological conditions

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Head lice products are applied to the hair and massaged in. A single application is used.

GROUP 1:
NeutraLice Lotion (containing Melaleuca Oil (Tea Tree Oil) 10% and Lavender Oil 1% - Key Pharmaceuticals Pty. Ltd.);

GROUP 2:
NeutraLice Advance (a suffocating product containing benzyl alcohol, mineral oil, polysorbate 80, sorbitan monooleate, Carbopol 934 and triethanolamine – Key Pharmaceuticals Pty. Ltd.)
Intervention code [1] 241381 0
Treatment: Drugs
Comparator / control treatment
GROUP 3:
Moov Head Lice Solution (containing Eucalyptus oil 11% and Lemon Tea Tree Oil 1% - Ego Pharmaceuticals Pty. Ltd.)
Control group
Active

Outcomes
Primary outcome [1] 253027 0
Ovicidal efficacy index (OEI)
The proportion of treated eggs hatched in-vitro divided by the proportion of pre-treated eggs hatched in-vitro expressed as a percentage up to and including 14 days after collection and incubation.
Timepoint [1] 253027 0
14 days after collection of eggs
Secondary outcome [1] 257841 0
Nil
Timepoint [1] 257841 0
Nil

Eligibility
Key inclusion criteria
Male or female primary school-aged children.
Presence of at least 20 live head lice eggs on the hair. The presence of live head lice eggs will be determined from a visual inspection of the hair.
Parent / Guardian have given written informed consent to their child’s participation in the trial.
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
History of allergies or adverse reactions to head lice products or the components of the specific products being tested.
Treatment with any head lice product in the 4 weeks prior to participation in this trial.
Treatment with hair dyes and bleaches within 4 weeks prior to participation in this trial.
Presence of scalp disease(s).

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
allocation schedule held by trial manager off site
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computer software
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 4
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
16/10/2009
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
90
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 243850 0
Commercial sector/Industry
Name [1] 243850 0
Key Pharmaceuticals Pty. Ltd.
Country [1] 243850 0
Australia
Primary sponsor type
Commercial sector/Industry
Name
Key Pharmaceuticals Pty. Ltd.
Address
12 Lyonpark Rd., Macquarie Park, NSW 2113
Country
Australia
Secondary sponsor category [1] 237205 0
None
Name [1] 237205 0
NA
Address [1] 237205 0
NA
Country [1] 237205 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 243966 0
University of Queensland Medical Research Ethics Committee
Ethics committee address [1] 243966 0
Ethics committee country [1] 243966 0
Australia
Date submitted for ethics approval [1] 243966 0
07/09/2009
Approval date [1] 243966 0
07/10/2009
Ethics approval number [1] 243966 0
2003000184

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 30360 0
Address 30360 0
Country 30360 0
Phone 30360 0
Fax 30360 0
Email 30360 0
Contact person for public queries
Name 13607 0
Phillip Altman
Address 13607 0
152 Cammeray Rd.
Cammeray, NSW 2062
Country 13607 0
Australia
Phone 13607 0
+61 (02)99088881
Fax 13607 0
+61 (02)99081617
Email 13607 0
[email protected]
Contact person for scientific queries
Name 4535 0
Phillip Altman
Address 4535 0
152 Cammeray Rd.
Cammeray, NSW 2062
Country 4535 0
Australia
Phone 4535 0
+61 (02)99088881
Fax 4535 0
+61 (02)99081617
Email 4535 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseAn ex vivo, assessor blind, randomised, parallel group, comparative efficacy trial of the ovicidal activity of three pediculicides after a single application - melaleuca oil and lavender oil, eucalyptus oil and lemon tea tree oil, and a "suffocation" pediculicide.2011https://dx.doi.org/10.1186/1471-5945-11-14
N.B. These documents automatically identified may not have been verified by the study sponsor.